4 free views remaining today

PCWH syndrome

ICD-10 Codes

Related ICD-10:

Description

PCWH syndrome, also known as Peripheral demyelinating neuropathy, Central dysmyelination, Waardenburg syndrome, and Hirschsprung disease, is a complex neurocristopathy that includes features of 4 distinct syndromes.

  • Peripheral demyelinating neuropathy: This refers to the degeneration of nerve fibers in the peripheral nervous system, leading to muscle weakness, numbness, and pain [1].
  • Central dysmyelination: This involves the abnormal development or maintenance of myelin sheaths in the central nervous system, resulting in cognitive impairment, seizures, and other neurological symptoms [2].
  • Waardenburg syndrome: This is a rare genetic disorder characterized by sensorineural hearing loss, pigmentary abnormalities (such as white forelock), and Hirschsprung disease [3].
  • Hirschsprung disease: This is a congenital condition where the nerves in the colon are missing or underdeveloped, leading to severe constipation and intestinal obstruction [4].

PCWH syndrome is caused by mutations in the SOX10 gene, which regulates the development and maintenance of neural crest derivatives, including Schwann cells, melanocytes, and enteric ganglion cells [5]. The phenotypic expression of PCWH syndrome can be highly variable, making diagnosis challenging. Clinical manifestations may mimic other neurocutaneous syndromes.

References: [1] Inoue et al., 2004 [2] Orphanet [3] Sienes Bailo, 2022 [4] Verheij, 2006 [5] OMIM

Additional Characteristics

  • Hirschsprung disease
  • Central dysmyelination
  • Peripheral demyelinating neuropathy
  • Waardenburg syndrome

Signs and Symptoms

PCWH syndrome, also known as Waardenburg-Shah syndrome, is a complex neurocristopathy that includes features of four distinct syndromes: peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease.

The signs and symptoms of PCWH syndrome can vary from person to person but often include:

  • Sensorineural hearing loss: A common feature of PCWH syndrome, which can range from mild to severe.
  • Pigmentary abnormalities: Such as skin hypopigmentation or blue irises (as seen in Waardenburg syndrome).
  • Hirschsprung disease: A condition characterized by the absence of ganglion cells in the distal colon and rectum, leading to constipation and intestinal obstruction.
  • Neurological features: Including neonatal hypotonia, intellectual deficit, nystagmus, and other motor disturbances.

Other possible signs and symptoms may include:

  • Peripheral neuropathy: A condition affecting the nerves outside the brain and spinal cord.
  • Central dysmyelination: A disorder of the myelin sheath surrounding nerve fibers in the central nervous system.
  • Distal arthrogryposis: A rare congenital disorder characterized by joint stiffness and contractures.

It's essential to note that each individual with PCWH syndrome may exhibit a unique combination of these symptoms, making diagnosis and management challenging.

Additional Symptoms

  • Sensorineural hearing loss
  • Peripheral neuropathy
  • Hirschsprung disease
  • Pigmentary abnormalities
  • Neurological features
  • Central dysmyelination
  • Distal arthrogryposis

Diagnostic Tests

Diagnostic Tests for PCWH Syndrome

PCWH (Pendred Syndrome with Hearing Loss and Hirschsprung Disease) syndrome is a complex neurocristopathy that includes features of peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease. Diagnostic tests are essential to confirm the diagnosis and rule out other conditions.

Brain MRI

A brain MRI should be done early to look for features of dysmyelination, suggestive of PCWH (1). This test can help identify abnormalities in the brain's white matter, which is characteristic of PCWH syndrome.

Genetic Testing

Molecular confirmation of a clinical diagnosis is crucial in PCWH syndrome. Genetic testing can be used to confirm the presence of mutations in the SOX10 gene, which is associated with Waardenburg syndrome and other conditions (9). Targeted genetic testing can also be useful for confirming the diagnosis and identifying at-risk relatives.

Other Diagnostic Tests

In addition to brain MRI and genetic testing, other diagnostic tests may be used to evaluate the presence of features of PCWH syndrome. These include:

  • Sensorineural hearing loss evaluation: This test is used to assess the degree of hearing loss in individuals with PCWH syndrome.
  • Pigmentary abnormalities evaluation: This test is used to assess the presence of pigmentary abnormalities, such as iris heterochromia and skin hypopigmentation, which are characteristic of Waardenburg syndrome.
  • Hirschsprung disease evaluation: This test is used to assess the presence of Hirschsprung disease, a condition characterized by the absence of ganglion cells in the colon.

References

  1. Early brain MRI for features of dysmyelination suggestive of PCWH (1)
  2. Genetic testing for mutations in the SOX10 gene (9)

Additional Diagnostic Tests

  • Genetic Testing
  • Brain MRI
  • Sensorineural hearing loss evaluation
  • Pigmentary abnormalities evaluation
  • Hirschsprung disease evaluation

Treatment

Based on the provided context, it appears that PCWH syndrome is a complex neurocristopathy that includes features of peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease.

Regarding drug treatment for PCWH syndrome, there are limited options available. However, some treatments have been mentioned in the context:

  • Sodium valproate is used to control seizures in patients with PCWH syndrome [4].
  • Hearing aids are recommended to ameliorate hearing impairment, as well as to improve language and communication skills [6].

It's worth noting that there is currently no specific treatment or cure for Waardenburg syndrome, which is one of the components of PCWH syndrome [8]. Treatment options for sensorineural hearing loss include cochlear implants, while Hirschsprung disease is treated surgically [9].

However, it seems that some treatments are focused on managing the symptoms rather than curing the underlying condition. For example, adenosine is used to convert narrow-complex supraventricular tachycardia (SVT) in Wolff-Parkinson-White (WPW) patients, which might be relevant for PCWH syndrome due to its association with WPW [12].

It's essential to consult a healthcare professional for personalized medical advice and treatment. They can provide more information on the available treatment options and create a tailored plan for each patient.

References:

[4] Jun 20, 2022 — Her seizure is well controlled now with a sodium valproate dose of 10 mg/kg two times per day. [6] Surgical treatment is required for Hirschsprung disease. Hearing aids are recommended to ameliorate hearing impairment, as well as to improve language, ... [8] Treatment. edit. There is currently no treatment or cure for Waardenburg syndrome. [9] Sensorineural hearing loss is treated with cochlear implants, Hirschsprung disease is treated surgically, and peripheral neuropathy and central dysmyelinating ...

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of PCWH Syndrome

PCWH syndrome, also known as Peripheral Demyelinating Neuropathy-Central Dysmyelinating Leukodystrophy-Waardenburg Syndrome-Hirschsprung Disease (PCWH), is a complex disorder that combines features of peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease. When diagnosing PCWH syndrome, it's essential to consider the differential diagnosis, which includes other forms of Waardenburg syndrome, piebaldism, ermine phenotype, as well as other causes of hearing loss or gastrointestinal disorders.

Other Forms of Waardenburg Syndrome

PCWH syndrome is one of four distinct clinical subtypes of Waardenburg syndrome (WS), which are defined based on the presence or absence of additional symptoms. The differential diagnosis includes WS1-4, with each subtype having unique features [7]. WS1, for example, is characterized by hearing loss, dystopia canthorum, and pigmentary abnormalities of the hair, skin, and eyes [9].

Piebaldism and Ermine Phenotype

The differential diagnosis also includes piebaldism, a rare genetic disorder that affects pigmentation in the skin and hair. Additionally, ermine phenotype is another condition that may be considered in the differential diagnosis of PCWH syndrome.

Other Causes of Hearing Loss or Gastrointestinal Disorders

Given the complex nature of PCWH syndrome, which combines features of peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease, it's essential to consider other causes of hearing loss or gastrointestinal disorders in the differential diagnosis.

References:

  • [6] PCWH syndrome is a complex disorder that combines features of peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease.
  • [4] The differential diagnosis includes other forms of Waardenburg syndrome, piebaldism and ermine phenotype, as well as other causes of hearing loss or gastrointestinal disorders.
  • [7] Four distinct clinical subtypes of WS (WS1-4) are defined based on the presence or absence of additional symptoms.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4319
owl#annotatedSource
t361465
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
ORDO:163746
oboInOwl#id
DOID:0090111
core#notation
DOID:0090111
oboInOwl#hasExactSynonym
Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease
rdf-schema#label
PCWH syndrome
IAO_0000115
A syndrome that is characterized by the association of the features of Waardenburg-Shah syndrome (sensorineural hearing loss, pigmentary abnormalities and Hirschsprung disease; see this term) with neurological features, including: neonatal hypotonia, intellectual deficit (of variable severity), nystagmus, progressive spasticity, ataxia and epilepsy, and has_material_basis_in heterozygous mutation in the SRY-box 10 (SOX10) gene on chromosome 22q13.
rdf-schema#subClassOf
t362077
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
relatedICD
http://example.org/icd10/E75.2
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.